These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28716191)

  • 1. Effect of immunologic solutions on sows and gilts on time to stability, and production losses in breeding herds infected with 1-7-4 PRRSv.
    Linhares DCL; Betlach C; Morrison RB
    Prev Vet Med; 2017 Sep; 144():112-116. PubMed ID: 28716191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of time to PRRSv-stability and production losses between two exposure programs to control PRRSv in sow herds.
    Linhares DC; Cano JP; Torremorell M; Morrison RB
    Prev Vet Med; 2014 Sep; 116(1-2):111-9. PubMed ID: 24931129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Cho H; Chae C
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Analysis of Immunization Strategies for PRRS Control [corrected].
    Linhares DC; Johnson C; Morrison RB
    PLoS One; 2015; 10(12):e0144265. PubMed ID: 26673898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Description of changes of key performance indicators and PRRSV shedding over time in a naïve breeding herd following a PRRS MLV exposure.
    Trevisan G; Johnson C; Benjamin N; Bradner L; Linhares DCL
    Transbound Emerg Dis; 2021 Nov; 68(6):3230-3235. PubMed ID: 34553831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.
    Geldhof MF; Van Breedam W; De Jong E; Lopez Rodriguez A; Karniychuk UU; Vanhee M; Van Doorsselaere J; Maes D; Nauwynck HJ
    Vet Microbiol; 2013 Dec; 167(3-4):260-71. PubMed ID: 24041768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four commercial PRRSV MLV vaccines in herds with co-circulation of PRRSV-1 and PRRSV-2.
    Oh T; Kim H; Park KH; Jeong J; Yang S; Kang I; Chae C
    Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():66-73. PubMed ID: 30961820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
    Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
    Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
    Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
    J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
    Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
    Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells.
    Bassaganya-Riera J; Thacker BJ; Yu S; Strait E; Wannemuehler MJ; Thacker EL
    Viral Immunol; 2004; 17(1):25-37. PubMed ID: 15018660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
    Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
    Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of simultaneous vaccination with two modified live virus vaccines against porcine reproductive and respiratory syndrome virus types 1 and 2 in pigs.
    Kristensen CS; Kvisgaard LK; Pawlowski M; Holmgaard Carlsen S; Hjulsager CK; Heegaard PMH; Bøtner A; Stadejek T; Haugegaard S; Larsen LE
    Vaccine; 2018 Jan; 36(2):227-236. PubMed ID: 29191738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of concurrent vaccination with modified-live PRRSV-1 and PRRSV-2 vaccines against heterologous dual PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
    Yang S; Oh T; Kang I; Park SJ; Chae C
    Vet Microbiol; 2019 Dec; 239():108497. PubMed ID: 31767085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The PRRSV-serumneutralization test detects gaps in herd immunity].
    Böttcher J; Alex M; Janowetz B; Müller S; Schuh C; Niemeyer H
    Berl Munch Tierarztl Wochenschr; 2014; 127(7-8):305-13. PubMed ID: 25080824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and biological characterization of a Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) causing significant clinical disease in the field.
    Kvisgaard LK; Larsen LE; Hjulsager CK; Bøtner A; Rathkjen PH; Heegaard PMH; Bisgaard NP; Nielsen J; Hansen MS
    Vet Microbiol; 2017 Nov; 211():74-83. PubMed ID: 29102125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy evaluation of three modified-live virus vaccines against a strain of porcine reproductive and respiratory syndrome virus NADC30-like.
    Zhou L; Yang B; Xu L; Jin H; Ge X; Guo X; Han J; Yang H
    Vet Microbiol; 2017 Aug; 207():108-116. PubMed ID: 28757009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A stochastic mathematical model of the within-herd transmission dynamics of Porcine Reproductive and Respiratory Syndrome Virus (PRRSV): fade-out and persistence.
    Evans CM; Medley GF; Creasey SJ; Green LE
    Prev Vet Med; 2010 Mar; 93(4):248-57. PubMed ID: 20004990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.